Prostate cancer, the second most diagnosed cancer in men
globally, is reshaping its care market with changing demographics
and treatment paradigms. BCC Research's latest report underscores
the pressing need for better treatments in metastatic
castration-resistant prostate cancer and the rising usage of PARP
inhibitors since 2020.
BOSTON, April 17,
2024 /PRNewswire/ -- "According to the
latest BCC Research study, the demand for Prevention and
Treatment of Prostate Cancer: Technologies and Global Markets
is estimated to increase from $37.9
billion in 2023 to $56.4
billion by the end of 2028, at a compound annual growth rate
(CAGR) of 8.3% during the forecast period of 2023-2028."
This report explores the comprehensive analysis of global
prostate cancer care in this research study, covering screening,
detection, and treatment. Gain insights into revenue forecasts,
future trends, and recommendations for market success. With data
estimated from 2022 and projections extending to 2028 by product
type and region, this study offers valuable perspectives for
stakeholders. Please note, that genetic testing for inherited
prostate cancer risk assessment is not included in the report's
scope.
Since its introduction in 2020, the utilization of PARP
inhibitors in prostate cancer treatment has experienced a notable
surge, reflecting a growing acceptance and recognition within the
medical community. Despite this advancement, it's striking that
over 60% of men eligible for prostate cancer screening have yet to
undergo screening, highlighting a substantial gap in detection
efforts. This sizable population of unscreened or inadequately
screened individuals presents a promising avenue for non-invasive
biomarker tests in the prostate cancer screening market, indicating
significant potential for addressing unmet needs and improving
patient outcomes.
Explore the full report on the burgeoning Prevention and
Treatment of Prostate Cancer for comprehensive insights and
forecasts – click here to Learn More.
Key Factors Driving the Prostate Cancer
Market:
Increasing Prevalence of Prostate Cancer: Prostate cancer
rates are rising globally due to factors like aging populations and
better detection methods. As awareness increases, more men are
seeking early diagnosis and treatment, driving demand for related
technologies and services.
Growing Trend Towards Active Surveillance and Screening:
Instead of aggressive treatment, there's a shift towards active
surveillance for low-risk prostate cancer cases. Regular screenings
aid in early cancer detection, enabling timely intervention and
better outcomes.
Trend Towards Personalized Care: Advancements in genomics
and precision medicine allow for tailored treatment plans.
Personalized therapies take into account an individual's genetic
profile, tumor characteristics, and overall health status.
Approvals for Metastatic Castration-Resistant Prostate Cancer
(mCRPC): New drugs and therapies are receiving regulatory
approvals for advanced prostate cancer, particularly metastatic
castration-resistant cases. These treatments prolong survival and
enhance the quality of life for patients.
Collaborations and Licensing Agreements: Companies are
joining forces to develop innovative solutions, share knowledge,
and expedite research. Licensing agreements facilitate access to
patented technologies, fostering progress in prostate cancer
management.
Request a Sample Copy of the Prevention and
Treatment of Prostate Cancer: Technologies and Global Markets
Report.
Report Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2022
|
Forecast Period
considered
|
2023-2028
|
Base year market
size
|
$35.3
billion
|
Market Size
Forecast
|
$56.4
billion
|
Growth Rate
|
CAGR of 8.3% from 2023
to 2028
|
Segment
Covered
|
By Type, Subtype, and
Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World
|
Key Market
Drivers
|
- Increasing
Prevalence of Prostate Cancer
- Growing Trend
Towards Active Surveillance and Screening
- Trend Towards
Personalized Care
- Approvals for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Collaborations and
Licensing Agreements
|
Report Segmentation: Understanding Prostate Cancer: How
They're Divided in Global Markets:
- Screening and Diagnosis: This includes early
detection methods like biomarker tests, digital rectal examinations
(DRE), and prostate biopsies to assess prostate cancer
risk.
- Pharmaceuticals: Medications such as hormone
therapy, antiandrogens, targeted therapy, PARP inhibitors, and
radioligand therapies play a crucial role in managing prostate
cancer.
- Chemotherapy and Immunotherapy:
Chemotherapy and immunotherapy are treatments that kill cancer
cells throughout the body and boost the immune system's response
against cancer, respectively.
- Surgery: Surgical procedures like radical
prostatectomy remove cancerous tissue, particularly the entire
prostate gland, to treat prostate cancer.
- Radiation Therapy Devices: Radiation therapy
devices, including external beam radiation therapy (EBRT) and
brachytherapy, target cancer cells using radiation to eradicate
prostate cancer.
This report on the Prevention and Treatment of Prostate
Cancer provides comprehensive insights and analysis, addressing the
following key questions:
1. What is the projected market size and growth
rate of the prostate cancer care market?
The global prostate cancer care market is estimated to be
around $37.9 billion in 2023. The
market is projected to reach $56.4
billion in 2028, growing at a CAGR of 8.3% during the
forecast period.
2. What segments are covered in the
market?
An in-depth analysis of the global prostate cancer care
market, including historical data and market projection on sales by
product type and subtypes, and region.
3. By product type, which segment will dominate
the market by the end of 2028?
By product type, the pharmaceutical segment is anticipated to
dominate the market by the end of 2028.
4. Which product type market is growing fastest
among all?
Pharmaceuticals is the fastest growing market.
Some of the Key Market Players Are:
- ABBOTT
- ACCURAY INC.
- ASTELLAS PHARMA INC.
- ASTRAZENECA
- BAYER AG
- DANAHER CORP.
- DENDREON PHARMACEUTICALS LLC
- ELEKTA
- F. HOFFMANN-LA ROCHE LTD.
- JOHNSON & JOHNSON SERVICES INC.
- PFIZER INC.
- SANOFI
- SIEMENS HEALTHINEERS AG
Browse More Related Reports:
Melanoma Therapeutics: Global Markets: This study
by BCC Research explores the melanoma treatment market, analyzing
treatment types, cancer stages, and therapeutic approaches. It
offers insights into current market status, growth forecasts until
2028, key players' market share, and company profiles.
Additionally, the report discusses the impact of COVID-19, emerging
technologies, and investment outlook within the market.
Global Acute Myeloid Leukemia (AML) Treatment Market:
Forecast and Trends: This report focuses on studying the global
market size of acute myeloid leukemia (AML) and its treatments. It
analyzes factors like treatment types, administration routes,
end-users, distribution channels, and regional trends to estimate
both current and historical market revenues. This comprehensive
analysis aims to uncover growth opportunities within the AML
market.
Directly Purchase a copy of the report with BCC
Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/prostate-cancer-advancements-in-prevention-and-treatment-drive-global-market-growth-302118532.html
SOURCE BCC Research LLC